
Colorado State University chemists have achieved a new feat in the realm of chemical design and synthesis: They’ve helped create the first example of a synthetic molecule, with an asymmetric oxygen atom as its centerpiece, that remains stable and nonreactive – despite this type of molecule’s tendency in nature to be touchy and short-lived.
What makes this feat unique is that the new molecule is chiral, which means it has a non-superimposable mirror image. Chiral molecules, which can be thought of as compounds with “left-” and “right-” handed versions, have long fascinated chemists because while they resemble each other, they can have drastically different properties. For example, limonene is a chiral molecule with two different mirror-image forms; one has the characteristic smell of oranges, and the other smells like lemons. In clinical environments, mirror-image forms of drug molecules can have divergent, even deleterious effects.
Robert Paton, professor in the Department of Chemistry, and Mihai Popescu, a postdoctoral researcher in Paton’s lab, worked on this project with collaborators at the University of Oxford, and their work was recently published in the journal Nature. Paton and Popescu led theoretical and computational studies that established new design rules for capturing a stable, chiral oxygen atom. This allowed their colleagues at Oxford to pursue the synthesis and analysis of these molecules, which are triaryl oxonium ions that can be isolated at room temperature.
Chiral molecules with carbon as their centerpiece have been widely explored, but in this study, the researchers used oxygen instead of carbon. No one had ever achieved this before, because oxygen atoms in naturally occurring chiral molecules, which are called oxoniums, tend to flip between their mirror-image forms; this makes them very reactive with their surroundings. This reactivity makes chiral oxonium molecules very difficult to synthesize and isolate in the laboratory.
With this work, the researchers have gifted molecular designers a new tool in their arsenal, chiral oxonium, much like a new type of building material with potentially unique properties. From drug discovery to materials engineering, the new oxonium could open up a whole new chapter in chemistry by design.
“The discovery of a fundamentally new example of molecular chirality demonstrates our ability as chemists to design and synthesize new matter based on a computational blueprint,” Paton said. “Given the fundamental importance of chirality in catalysis, medicine and materials, it will be exciting to explore the properties of chiral oxygen atom-containing compounds in future studies.”
Reference
Control of stereogenic oxygen in a helically chiral oxonium ion
Owen Smith, Mihai V. Popescu, Madeleine J. Hindson, Robert S. Paton, Jonathan W. Burton & Martin D. Smith

Mecwins has described its AVAC technology, which labels target proteins with plasmonic nanoparticles and counts each one individually by dark-field micro-spectrophotometry. The AVAC Analyzer reaches femtogram-range sensitivity.
Hesperos has received an SBIR Phase II grant (R44AI197758) from NIAID to expand its Malaria-on-a-Chip platform, adding support for viable, replicating parasite strains and predictive PK/PD modeling.

UCLA researchers have shown that briefly squeezing a cell's nucleus for milliseconds can loosen tightly packed DNA and make CRISPR activation far more effective at reprogramming cell identity. After mapping which genomic regions opened, they aimed guide RNAs at those sites, raising the share of mouse skin cells converted to neurons from about 3% to 10%. Adding a priming step that activated Oct4 pushed conversion to roughly 40%.
This week in nanotech
$271M raised
7 funding rounds · 31 deals tracked
New products
Orion Sputtering Deposition SystemsAJA International Featured
Nion-compatible In Situ STEM Holders for Electrical BiasingHummingbird Scientific Featured
GiiiGiiMarket insights
Last 30 days: Quantum Technologies drew the most money: $3.17B.
Money raised per month
Behind the deal
Who led Institut de Microelectronica de Barcelona (IMB-CNM, CSIC)’s $185.7M Grant?
See the investors with Insights Pro →